$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
04/30/2023 10:14:49 PM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
04/15/2023 6:22:59 PM |
Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga. |
@Prediksiparlay88 |
04/06/2023 2:43:45 AM |
panda448: Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga.com/pressreleases/23/04/ |
@arbo99 |
04/06/2023 12:42:29 AM |
Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga.com/pressreleases/23/04/g31629187/oncotelic-announces-release-of-pet2dao- |
@basahi |
04/05/2023 10:41:39 PM |
https://seekingalpha.com/symbol/otcc |
@mick |
02/27/2023 3:19:00 AM |
https://seekingalpha.com/symbol/onlg |
@mick |
02/27/2023 3:19:00 AM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
02/26/2023 11:48:33 PM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
02/05/2023 11:44:04 PM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
12/18/2022 11:31:41 PM |
yes /\ Oncotelic Therapeutics Inc. |
@mick |
11/21/2022 3:35:22 PM |
Charts don't matter. |
@Skim2025 |
11/21/2022 2:47:01 PM |
http://www.stockta.com/cgi-bin/analysis.pl?symb=otlc |
@mick |
10/23/2022 7:27:15 PM |
https://www.otcmarkets.com/stock/$OTLC/security |
@mick |
10/23/2022 7:21:12 PM |
#248
$MATN & $GILD?????,6;41a.m. 07-07-2020 .M. Mateon Therapeutics Appts. mick |
@mick |
10/23/2022 7:20:31 PM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
10/23/2022 7:20:05 PM |
panda448: Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID: https://www.yahoo.com/now/ |
@hamidakbari |
10/17/2022 10:48:26 PM |
Management is inept |
@chadco |
10/13/2022 8:58:42 AM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
08/31/2022 10:16:31 PM |
$OTLC
Oncotelic Therapeutics Inc (QB) |
@mick |
07/17/2022 10:16:56 PM |
Surprised at the lack of interest |
@RHoogendam |
06/20/2022 8:51:58 PM |
Looks like we should expect success in the |
@cougarhsv |
06/20/2022 5:14:57 PM |
panda448: Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO Intern |
@RESPREE |
06/15/2022 9:04:02 PM |
Oncotelic Announces Pipeline Presentation and IPO Update of |
@R1J2A3 |
06/15/2022 8:42:56 PM |
Oncotelic Therapeuti ($OTLC) |
@mick |
06/06/2022 4:03:58 AM |
nice news...https://www.otcmarkets.com/stock/$OTLC/news/Oncotelic-Therapeutics-Re |
@yastockboy |
05/25/2022 1:11:48 PM |
panda448: ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 2021, PRODUCT DEVELOPMENT INITIATIVES AN |
@Turnertroy |
05/23/2022 5:25:35 PM |
ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO |
@mick |
05/23/2022 5:02:34 PM |
panda448: Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer: https://oncotelic.irpass.com/ |
@Krissy |
05/04/2022 5:04:13 PM |
panda448: Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer: https://oncotelic.irpass.com/Oncot |
@schleprock |
05/04/2022 5:04:02 PM |
Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief |
@mhoaly |
05/04/2022 4:55:19 PM |
Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory |
@ambroscopper |
05/04/2022 4:54:27 PM |
Oncotelic Therapeuti ($OTLC) |
@mick |
05/01/2022 7:58:26 PM |
$OTLC on watch due to Daily Chart increasing |
@HERB |
04/20/2022 1:34:05 PM |
$OTLC ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED |
@LaniFFoss |
04/19/2022 3:18:52 PM |
This Little Known Cancer Play has been Crushing |
@stocksandstuff |
04/14/2022 1:49:22 PM |
$OTLC Company Profile and Technical Chart Analysis |
@TALON55 |
04/13/2022 2:12:54 PM |
$OTLC The Accumulation here is off the charts |
@jfarrar42 |
04/12/2022 1:39:27 PM |
$OTLC Chart Forming Beautiful BULL FLAG here! Bullish |
@mmazher |
04/11/2022 1:16:45 PM |
$OTLC Letter to Oncotelic Shareholders on the Recently |
@mortonrj |
04/08/2022 1:42:18 PM |
$OTLC a bargain here, The JV will |
@Mohitpatil |
04/07/2022 3:27:55 PM |
news https://www.globenewswire.com/news-release/2022/04/07/2418633/0/en/Letter-t |
@sirphoenix |
04/07/2022 3:18:08 PM |
panda448: Oncotelic; Announcing Successful Joint Venture and Diving into Benefits for Shareholders: https://ww |
@lorensmoore |
04/04/2022 8:19:15 PM |
Oncotelic; Announcing Successful Joint Venture and Diving into |
@wazzat1961 |
04/04/2022 6:31:03 PM |
panda448: Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology Investor Conference: https://www. |
@coinvigilante |
04/01/2022 6:21:28 PM |
Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology Investor |
@tomsoundmusic |
04/01/2022 5:17:45 PM |
panda448: Oncotelic JV Financing: https://www.youtube.com/watch?v=k0Zj59shmw0 |
@garrettwkfme |
03/21/2022 7:48:37 PM |
Oncotelic JV Financing: https://www.youtube.com/watch?v=k0Zj59shmw0 |
@lboren44 |
03/21/2022 7:44:03 PM |
panda448: Oncotelic; Looking at Industry Comparison for the Company: https://www.youtube.com/watch?v=Dnkmg0k7W |
@dfunaro |
03/15/2022 11:42:49 PM |
panda448: Oncotelic; Discussing the Company's Development Pipeline: https://www.youtube.com/watch?v=FPBbAif6M9 |
@Jballoon1 |
03/15/2022 11:40:57 PM |
panda448: Oncotelic; Diving into the Company's Outlook for 2022: https://www.youtube.com/watch?v=FPBbAif6M9I |
@ortigoza21 |
03/15/2022 11:40:43 PM |
Oncotelic; Looking at Industry Comparison for the Company: https://www.youtube.c |
@soon2b70 |
03/15/2022 8:40:37 PM |
Oncotelic; Discussing the Company's Development Pipeline: https://www.youtube.c |
@rlong |
03/15/2022 7:51:33 PM |
Oncotelic; Diving into the Company's Outlook for 2022: https://www.youtube.com/ |
@nakul |
03/15/2022 7:40:43 PM |
Oncotelic Therapeuti ($OTLC) |
@mick |
03/12/2022 8:56:43 PM |
panda448: Oncotelic to Present New Studies on its TGF- Program at the American Association for Cancer Researc |
@Shummi |
03/10/2022 7:17:44 PM |
Oncotelic to Present New Studies on its TGF- |
@pauldgreen |
03/10/2022 6:45:40 PM |
Questions: I did some DD and was |
@mugs1957 |
03/08/2022 3:57:38 AM |
panda448: Oncotelic; An Introduction to CFO Amit Shah & His Industry Background: https://www.youtube.com/watch |
@selectpipes |
03/02/2022 11:00:46 PM |
Oncotelic; An Introduction to CFO Amit Shah & |
@dkbuchanan |
03/02/2022 10:54:58 PM |
Oncotelic; An Introduction to CBO GM of AI |
@thara |
02/22/2022 10:46:55 PM |
Oncotelic; An Introduction to Chief Clinical Officer Anthony |
@Joewharton2 |
02/22/2022 10:45:57 PM |
Oncotelic Therapeuti ($OTLC) |
@mick |
02/06/2022 9:59:30 PM |
panda448: Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma: |
@randy247 |
01/05/2022 4:37:47 PM |
panda448: Oncotelic Announces that ORF8 Mutations are Driving the Evolution of the Delta and the Omicron Varia |
@Makeitgoup1977 |
12/22/2021 4:34:33 PM |
panda448: Oncotelics Dr. Anthony Maida to Present at 2nd Annual TGF- for Immuno-Oncology Drug Development Su |
@nimbleappgenie |
12/14/2021 5:07:13 PM |
panda448: Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19: https://www.asbestos.com/news/2021 |
@Marketwirenewstome |
12/09/2021 12:37:25 AM |
panda448: Oncotelic 2021 Q3 Report, Litchfield reiterates $4 12 month PT: https://www.otcmarkets.com/financial |
@nishaparmar |
12/07/2021 11:44:09 PM |
panda448: Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK) |
@CyMoo1 |
12/04/2021 12:26:03 AM |
panda448: New Oncotelic Therapeutics Inc (OTLC) Stock Analysis and News Coverage: https://www.youtube.com/watc |
@36wutanclan |
11/29/2021 11:33:47 PM |
panda448: Oncotelic Therapeutics Inc (OTLC) stock news and analysis: https://www.youtube.com/watch?v=M-4sS-P0O |
@michaelphamelan |
11/23/2021 12:55:18 AM |
panda448: Oncotelic Announces Successful Completion of Safety Evaluation of First Cohort in OT-101/IL-2 Combin |
@DanBorn |
11/16/2021 2:27:46 PM |
panda448: Another TGF-beta acquisition- bode well for $OTLC/ OT-101 TGF beta inhibitor https://www.thepharm |
@Jack30ny |
11/10/2021 10:47:11 PM |
panda448: $OTLC in immunotherapy space: Immunotherapy (Checkpoint Inhibitors, CAR-T, IL-2, Vaccin |
@Biggbear |
11/05/2021 11:56:33 PM |
panda448: ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL PROGRAMS INCLUDING C001 COVID STUDY: https://onc |
@Brinx123 |
10/23/2021 12:15:01 AM |
panda448: ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCT |
@freddie |
10/05/2021 10:19:24 PM |
panda448: OT-101 an antisense against TGF-2 for the treatment of solid tumors with focus on brain cancer |
@pennytripper |
09/30/2021 12:17:18 AM |
panda448: ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMA |
@Kurtj2017 |
09/07/2021 10:46:29 PM |
panda448: PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE AGAINST MILD AND MODERATE COVID-19: https://oncotelic.ir |
@Mathewhewlett |
09/07/2021 10:45:04 PM |
panda448: ONCOTELIC AND GOLDEN MOUNTAIN PARTNERS FORMING A JOINT VENTURE FOR IPO: https://finance.yahoo.com/ne |
@OlinSain |
08/16/2021 11:04:07 PM |
CaptnAmerca: New 8-K |
@Kari |
07/20/2021 2:31:08 PM |
CaptnAmerca: ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY |
@mmgmm |
06/15/2021 1:24:41 PM |
panda448: Mateon Therapeutics Inc. has changed its name to Oncotelic Therapeutics Inc. New ticker symbol is OT |
@garrettdeasy |
03/31/2021 7:24:28 PM |
panda448: Litchfield Hills upgrade price target to $4 from $3: https://www.oncotelic.com/wp-content/uploads/20 |
@Smartypants |
03/05/2021 7:04:49 PM |
panda448: MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH PULMOHEAL CLINICAL DATA AGAINST COVID-19 IN PEER-RE |
@runyabe |
03/04/2021 1:41:37 AM |
panda448: MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA: https://finance.yahoo.com/news/mateon-partnere |
@beackod |
02/16/2021 11:04:51 PM |
panda448: Targeting TGF-b pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mi |
@Ken |
02/01/2021 11:05:26 PM |
panda448: MATEON LAUNCHING MOBILE APP, ARTIHEALTH, FOR REMOTE RESPIRATORY HEALTH ASSESSMENT: https://finance. |
@Deimantele |
01/27/2021 1:15:48 AM |
panda448: Zacks Small Cap Research: MATN: POSITIVE INTERIM RESULTS FOR ARTIVEDATM; WILL APPROACH FDA FOR EUA.. |
@Nicky |
01/15/2021 12:25:15 AM |
panda448: MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTI |
@timothylw |
01/13/2021 7:35:51 PM |
panda448: Litchfield Hills Research MATN-Buy-$3 PT: http://www.hillsresearch.com/wp-content/uploads/2021/01/MA |
@Liudmila |
01/08/2021 6:53:46 PM |
panda448: We might need to redefine our approach to drug discovery and approval to be prepared for the future: |
@Wildkatt |
01/08/2021 12:02:27 AM |
panda448: MATEONS GLOBAL STUDY FOR OT-101/ TGF- INHIBITOR AGAINST COVID-19 ENROLLS AND TREATS ITS FIRST PATI |
@echavez76 |
12/30/2020 7:48:50 PM |
panda448: Initiating coverage of MATN, Buy rating and $3 PT: https://www.hillsresearch.com/current-research |
@clintong |
12/15/2020 6:17:00 PM |
panda448: Positive early results in treating COVID-19: https://scr.zacks.com/News/Press-Releases/Pre |
@Zachlark |
12/15/2020 6:13:54 PM |
TonyCorvette: $MATN New$$$ |
@Ford2000 |
11/04/2020 12:41:50 PM |
mick: $MATN I LIKE |
@mick |
08/23/2020 10:06:29 PM |